{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:55:38Z","timestamp":1790978138111,"version":"4.1.0"},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"12","funder":[{"name":"Clinical Research Committee of the University Hospital of N\u00eemes"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2011]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>dministration of heparin in the secondary prevention of placental vascular complications is still experimental. In women with a previous severe pre-eclampsia, we investigated the effectiveness of enoxaparin, a low-molecular-weight heparin, in preventing these complications. Between January 2000 and January 2010, 224 women from the NOHA First cohort, with previous severe pre-eclampsia but no foetal loss during their first pregnancy and negative for antiphospholipid antibodies, were randomised to either a prophylactic daily dose of enoxaparin starting from the positive pregnancy test (n=112), or no enoxaparin (n=112). The primary outcome was a composite of at least one of the following: pre-eclampsia, abruptio placentae, birthweight \u22645th percen-tile, or foetal loss after 20 weeks. Enoxaparin was associated with a lower frequency of primary outcome: 8.9% (n=10\/112) vs. 25 % (28\/112), p=0.004, hazard ratio = 0.32, 95% confidence interval (0.16\u20130.66), p=0.002. Enoxaparin was safe, with no obvious side-effect, no thrombocytopenia nor major bleeding event excess. This pilot study shows that enoxaparin given early during the second pregnancy decreases the occurrence of placental vascular complications in women with a previous severe pre-eclampsia during their first pregnancy.<\/jats:p><jats:p>The pilot randomised controlled NOH-PE trial<\/jats:p>","DOI":"10.1160\/th11-05-0340","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T12:59:51Z","timestamp":1316696391000},"page":"1053-1061","source":"Crossref","is-referenced-by-count":76,"title":["Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia"],"prefix":"10.1160","volume":"106","author":[{"given":"C\u00e9line","family":"Chauleur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Molinari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Mar\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Fabbro-Peray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Qu\u00e9r\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Lefrant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Dauzat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Gris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"10.1160\/TH11-05-0340-1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.06.044"},{"key":"10.1160\/TH11-05-0340-2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2007.03.005"},{"key":"10.1160\/TH11-05-0340-3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2009.02317.x"},{"key":"10.1160\/TH11-05-0340-4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2255"},{"key":"10.1160\/TH11-05-0340-5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02594.x"},{"key":"10.1160\/TH11-05-0340-6","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000266983.77458.71"},{"key":"10.1160\/TH11-05-0340-7","first-page":"CD004659","volume":"2","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1160\/TH11-05-0340-8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03230.x"},{"key":"10.1160\/TH11-05-0340-9","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-03-0167"},{"key":"10.1160\/TH11-05-0340-10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01581.x"},{"key":"10.1160\/TH11-05-0340-11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02423.x"},{"key":"10.1160\/TH11-05-0340-12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"10.1160\/TH11-05-0340-13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1994.04060457.x"},{"key":"10.1160\/TH11-05-0340-14","doi-asserted-by":"publisher","DOI":"10.1002\/uog.2733"},{"key":"10.1160\/TH11-05-0340-15","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2010.1084"},{"key":"10.1160\/TH11-05-0340-16","first-page":"293","volume":"62","author":"Chiaffarino","year":"2010","journal-title":"Minerva Ginecol"},{"key":"10.1160\/TH11-05-0340-17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","volume":"45","author":"Mello","year":"2005","journal-title":"Hypertension"},{"key":"10.1160\/TH11-05-0340-18","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000265804.09161.0d"},{"key":"10.1160\/TH11-05-0340-19","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2009.08.001"},{"key":"10.1160\/TH11-05-0340-20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.10.025"},{"key":"10.1160\/TH11-05-0340-21","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(11)70018-4"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH11-05-0340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T06:28:45Z","timestamp":1521613725000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH11-05-0340"}},"subtitle":["The pilot randomised controlled NOH-PE trial"],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":21,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,27]]},"published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1160\/th11-05-0340","relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}